Osteoporosis
Conditions
Keywords
osteoporosis, postmenopausal, patient compliance, compliance, diphosphonates, bisphosphonates
Brief summary
The purpose of the study is to provide information about the rate of response and persistence to drug therapies for osteoporosis. Another issue examined in this study refers to the preferences and concerns about future treatments in patients during drug holiday.
Interventions
OTHERQuestionnaires about compliance and persistence with bisphosphonates treatment
Sponsors
Meir Medical Center
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
40 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Postmenopausal women * Diagnosis of osteoporosis in the medical record * At least one prescription drug to treat osteoporosis in the last 5 years * Insured by Clalit Health Services * Hebrew-speaking capability and readiness to answer a questionnaire
Exclusion criteria
* Premenopausal women * No diagnosis of osteoporosis in the medical record * No treatment for osteoporosis in the last 5 years * Women who do not speak Hebrew or are unable to answer a questionnaire
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Compliance and persistence to osteoporosis drug therapy | Participants will be followed for the duration of their clinic visit, an average of 5 hours | Data collection will be done by questionnaires and from the medical record of the patient. The information collected will include: demographic information, measurements of bone density, additional information about the disease and treatment that the patient receives,prescription purchases and additional drugs the patient is taking (steroids, PPI's(Proton Pump Inhibitors) / H2 receptor antagonists and NSAIDs(Non Steroidal Anti Inflammatories)). |
Countries
Israel
Contacts
Primary ContactPnina Rotman, M.D
Outcome results
None listed